Invesco’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
319,112
+116,581
| +58% | +$590K | ﹤0.01% | 2651 |
|
|
2025
Q1 | $1.07M | Buy |
202,531
+23,912
| +13% | +$126K | ﹤0.01% | 2798 |
|
|
2024
Q4 | $1.21M | Buy |
178,619
+63,068
| +55% | +$426K | ﹤0.01% | 2828 |
|
|
2024
Q3 | $761K | Buy |
115,551
+7,284
| +7% | +$48K | ﹤0.01% | 3023 |
|
|
2024
Q2 | $812K | Buy |
108,267
+9,703
| +10% | +$72.8K | ﹤0.01% | 3033 |
|
|
2024
Q1 | $983K | Sell |
98,564
-22,322
| -18% | -$223K | ﹤0.01% | 2988 |
|
|
2023
Q4 | $1.19M | Buy |
120,886
+13,796
| +13% | +$136K | ﹤0.01% | 2807 |
|
|
2023
Q3 | $819K | Buy |
107,090
+580
| +0.5% | +$4.44K | ﹤0.01% | 2956 |
|
|
2023
Q2 | $796K | Sell |
106,510
-12,705
| -11% | -$94.9K | ﹤0.01% | 2988 |
|
|
2023
Q1 | $795K | Buy |
119,215
+74,595
| +167% | +$498K | ﹤0.01% | 2999 |
|
|
2022
Q4 | $344K | Sell |
44,620
-332
| -0.7% | -$2.56K | ﹤0.01% | 3430 |
|
|
2022
Q3 | $478K | Buy |
44,952
+669
| +2% | +$7.11K | ﹤0.01% | 3245 |
|
|
2022
Q2 | $361K | Sell |
44,283
-350
| -0.8% | -$2.85K | ﹤0.01% | 3471 |
|
|
2022
Q1 | $320K | Buy |
44,633
+1,160
| +3% | +$8.32K | ﹤0.01% | 3572 |
|
|
2021
Q4 | $745K | Buy |
+43,473
| New | +$745K | ﹤0.01% | 3187 |
|
|
2021
Q3 | – | Sell |
-5,612
| Closed | -$205K | – | 4015 |
|
|
2021
Q2 | $205K | Buy |
+5,612
| New | +$205K | ﹤0.01% | 3753 |
|